Chronic total occlusion percutaneous coronary intervention failure: Learning from failure

Aris Karatasakis1, Emmanouil S Brilakis2

  • 1Department of Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.

Insights

Preventing and managing complications is key to successful chronic total occlusion percutaneous coronary intervention. Failure often stems from guidewire crossing issues in antegrade approaches or collateral crossing and reverse CART in retrograde interventions.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Chronic total occlusion (CTO) percutaneous coronary intervention (PCI) success rates are operator-dependent.
  • Complications are a significant factor contributing to CTO intervention failure.
  • Preventive strategies and appropriate complication management are crucial for optimal outcomes.

Discussion:

  • Antegrade CTO PCI failure commonly results from the inability to cross the occlusion with a guidewire.
  • Retrograde CTO PCI failure mechanisms include difficulty crossing collaterals (33%), inability to perform reverse Coronary Artery Revascularization Technique (CART) (33%), and microcatheter crossing failure post-guidewire (33%).

Key Insights:

  • Guidewire crossing is the primary challenge in antegrade CTO PCI.
  • Retrograde CTO PCI failure is multifactorial, involving collateral access, reverse CART, and microcatheter manipulation.
  • Understanding these specific failure points is essential for improving procedural success.

Outlook:

  • Further research into novel guidewire and microcatheter technologies may mitigate crossing failures.
  • Enhanced training in retrograde techniques, particularly reverse CART, could improve success rates.
  • Developing standardized protocols for complication management in CTO PCI is warranted.

Related Concept Videos

Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
455
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
757
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
936
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.1K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
487